DIA India 8th Pharmacovigilance Conference

At this event, DIA India brings together key regulatory authorities, leading industry subject matter experts and thought leaders for collaborative discussions on driving innovation in drug safety and pharmacovigilance.

Overview

Through the last 7 years, the single point agenda of the DIA India Pharmacovigilance flagship conferences has been to keep all the stakeholders abreast of the latest trends and updates from the rapidly evolving world of drug safety.

Today, innovations are revolutionizing the entire healthcare development and commercialization landscape and the need of the hour is, strategies that pave the way for a smarter and more patient centric tomorrow.

As we move into a new decade, healthcare in 2030 demands the onset of innovations that will revolutionize the entire gamut of drug safety, pharmacovigilance, risk management and post marketing surveillance. This year we invite you to be part of exciting sessions and round table discussions on the most happening topics pertinent to the industry today.

Download Registration Form

Featured

Want to learn more about DIA India 8th Pharmacovigilance Conference? You've come to the right site!

Program Committee

Moin Don Adjunct Prof Jamia Hamdard Delhi, Lead:South Asia Chapter (ISoP), International
Society of Pharmacovigilance (ISoP), Founder & CEO PVCON Consulting, , India
Krishna Bahadursingh Head of Patient Safety
Bristol Myers Squibb, Japan
Shirish Dattatraya Sherlekar, MD Global Head Life Sciences Practice
Tata Consultancy Services, India
Ramandeep Singh Service Delivery Lead
Accenture Services Pvt. Ltd., India
J Vijay Venkatraman, MD, MBA Managing Director and CEO
Oviya MedSafe, India
Prashant Joshi, RPh Executive Director - Drug Safety
Labcorp Drug Development, India
Milind Sardesai GM - Medical Safety Services
Cognizant Technology Solutions India, India